Epstein-Barr virus (EBV) reactivation is a very frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts for EBV-lymphoproliferative disease following T-cell depleted SCT

J.W.J van Esser, B. van der Holt, E. Meijer, H.G.M. Niesters, R. Trenschel, S.F.T. Thijsen, A.M. van Loon, F. Frassoni, A. Bacigalupo, U.W. Schaefer, A.D.M.E. Osterhaus, J.W. Gratama, B. Lowenberg, L.F. Verdonck, J.J. Cornelissen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)972-978
Number of pages7
Issue number4
Publication statusPublished - 2001

Cite this